TCW Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $457K | Buy |
7,280
+139
| +2% | +$9.68K | ﹤0.01% | 491 |
|
|
2025
Q4 | $474K | Sell |
7,141
-1,030,054
| -99% | -$66.6M | ﹤0.01% | 483 |
|
|
2025
Q3 | $69.8M | Buy |
1,037,195
+37,426
| +4% | +$2.96M | 0.58% | 51 |
|
|
2025
Q2 | $87.3M | Buy |
999,769
+62,270
| +7% | +$4.88M | 0.68% | 37 |
|
|
2025
Q1 | $64M | Buy |
937,499
+67,403
| +8% | +$5.5M | 0.57% | 51 |
|
|
2024
Q4 | $67.7M | Buy |
870,096
+19,962
| +2% | +$1.48M | 0.57% | 53 |
|
|
2024
Q3 | $57M | Sell |
850,134
-21,344
| -2% | -$1.75M | 0.5% | 58 |
|
|
2024
Q2 | $98.8M | Buy |
871,478
+61,461
| +8% | +$7.77M | 0.88% | 31 |
|
|
2024
Q1 | $112M | Sell |
810,017
-36,645
| -4% | -$4.61M | 1.14% | 24 |
|
|
2023
Q4 | $105M | Sell |
846,662
-99,171
| -10% | -$10.1M | 1.17% | 22 |
|
|
2023
Q3 | $88.2M | Sell |
945,833
-80,870
| -8% | -$9.12M | 1.11% | 24 |
|
|
2023
Q2 | $132M | Buy |
1,026,703
+28,848
| +3% | +$3.49M | 1.46% | 16 |
|
|
2023
Q1 | $116M | Buy |
997,855
+10,401
| +1% | +$1.16M | 1.48% | 16 |
|
|
2022
Q4 | $112M | Sell |
987,454
-30,433
| -3% | -$3.34M | 1.6% | 18 |
|
|
2022
Q3 | $82M | Sell |
1,017,887
-14,271
| -1% | -$1.21M | 1.2% | 24 |
|
|
2022
Q2 | $76.9M | Sell |
1,032,158
-80,682
| -7% | -$7.36M | 1.01% | 27 |
|
|
2022
Q1 | $142M | Sell |
1,112,840
-46,088
| -4% | -$5.04M | 1.36% | 17 |
|
|
2021
Q4 | $156M | Sell |
1,158,928
-6,288
| -0.5% | -$904K | 1.28% | 22 |
|
|
2021
Q3 | $159K | Buy |
1,165,216
+9,412
| +0.8% | +$1.19M | 0.41% | 19 |
|
|
2021
Q2 | $123M | Buy |
1,155,804
+134,860
| +13% | +$13M | 1.07% | 24 |
|
|
2021
Q1 | $91.7M | Buy |
+1,020,944
| New | +$95.8M | 0.88% | 31 |
|
|
2016
Q3 | – | Sell |
-72,480
| Closed | -$1.44M | – | 664 |
|
|
2016
Q2 | $1.44M | Buy |
72,480
+3,556
| +5% | +$60.5K | 0.01% | 402 |
|
|
2016
Q1 | $1.17M | Buy |
68,924
+8,648
| +14% | +$144K | 0.01% | 444 |
|
|
2015
Q4 | $1.23M | Sell |
60,276
-76,460
| -56% | -$1.59M | 0.01% | 454 |
|
|
2015
Q3 | $2.94M | Sell |
136,736
-86,024
| -39% | -$1.92M | 0.02% | 272 |
|
|
2015
Q2 | $4.45M | Sell |
222,760
-16,936
| -7% | -$297K | 0.03% | 246 |
|
|
2015
Q1 | $3.73M | Sell |
239,696
-93,576
| -28% | -$1.41M | 0.02% | 463 |
|
|
2014
Q4 | $4.59M | Sell |
333,272
-27,320
| -8% | -$334K | 0.02% | 425 |
|
|
2014
Q3 | $3.6M | Sell |
360,592
-9,036
| -2% | -$92.4K | 0.01% | 568 |
|
|
2014
Q2 | $3.67M | Sell |
369,628
-30,476
| -8% | -$270K | 0.02% | 571 |
|
|
2014
Q1 | $4.14M | Sell |
400,104
-684,832
| -63% | -$7.08M | 0.02% | 532 |
|
|
2013
Q4 | $9.61M | Sell |
1,084,936
-174,340
| -14% | -$1.38M | 0.04% | 337 |
|
|
2013
Q3 | $8.89M | Sell |
1,259,276
-765,284
| -38% | -$4.85M | 0.04% | 339 |
|
|
2013
Q2 | $11.4M | Buy |
+2,024,560
| New | +$9.7M | 0.06% | 274 |
|
Other funds holding DXCM
VCM
VPM
TCW Group's DXCM Position: Q1 2026 in Review
TCW Group increased its DexCom (DXCM) stake by 1.9% in Q1 2026, buying an estimated $9.68K and bringing the position to 7,280 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #491.
TCW Group first reported a position in DXCM in Q2 2013 and has held it in 34 quarters since. The position peaked at $156M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- TCW Group held 7,280 shares of DexCom worth $457K as of Q1 2026.
- TCW Group bought 139 DexCom shares in Q1 2026, an estimated $9.68K.
- DexCom made up ﹤0.01% of TCW Group's portfolio in Q1 2026, its #491 holding.
- TCW Group first reported a position in DexCom in Q2 2013 and has held it in 34 quarters since.
- TCW Group's DexCom position peaked at $156M in Q4 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.